Inventor

EISSENSTAT MICHAEL

US24 patents

⚠️ This page may combine multiple inventors who share the name “EISSENSTAT MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EISSENSTAT MICHAEL

SEQUOIA PHARMACEUTICALS INC

Compositions and methods for inhibiting cytochrome P450

Resistance-repellent retroviral protease inhibitors

Benzofuran derived HIV protease inhibitors

5-substituted benzofurans as inhibitors of cytochrome P450 2D6

Resistance-repellent retroviral protease inhibitors

Resistance-repellent retroviral protease inhibitors

Compositions and methods for inhibiting cytochrome P450

Diamide inhibitors of cytochrome P450

Compositions and methods for inhibiting cytochrome P450

Compositions and methods for inhibiting cytochrome P450 2D6

EISSENSTAT MICHAEL

Benzofuran-containing amino acid inhibitors of cytochrome P450

HIV protease inhibitor and cytochrome p450 inhibitor combinations

Benzofuran derived HIV protease inhibitors

Diamide inhibitors of cytochrome P450

Compositions and methods for inhibiting cytochrome P450

5-substituted benzofurans as inhibitors of cytochrome P450 2D6

HCV protease inhibitors

Methods for inhibiting drug degradation

TIBOTEC PHARM LTD

Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

Small molecule entry inhibitors

US HEALTH

Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor

ERICKSON JOHN W

Resistance-repellent retroviral protease inhibitors

SEQUOIA PHARMACEUTICALS

Resistance-repellent retroviral protease inhibitors

MAJER PAVEL

Bimacrocylic HCV NS3 protease inhibitors